If you enjoy this content, please share it with a colleague
SuperSonic Imagine
RELATED CONTENT
January 29, 2021— Hologic, Inc. announced the expansion of its ultrasound portfolio with the launch of the new ...
SuperSonic Imagine announced the publication of the results of its prospective multicentric clinical study conducted in China to validate the performance of ShearWave Elastography (SWE) in evaluating liver fibrosis severity in patients with chronic hepatitis B (HBV). SWE enables tissue stiffness to be instantly visualised and measured in kPa. The results of the study were published in two articles that appeared in the peer-reviewed journals, Radiology and Gut.
SuperSonic Imagine will introduce the new generation of its Aixplorer Mach 30 breast ultrasound solution at the 2019 Society of Breast Imaging/American College of Radiology (SBI/ACR) Breast Imaging Symposium, April 4-7 in Hollywood, Fla. The SBI‘s annual symposium is the largest breast imaging conference in the world and this year, the symposium will focus on Value in Breast Imaging. SuperSonic Imagine will highlight new features and better performance with features like SWE Plus and SonicPure.
SuperSonic Imagine recently exhibited at The Liver Meeting, held Nov. 9-13 in San Francisco, where the company introduced the U.S. Food and Drug Administration (FDA)-cleared Aixplorer Mach 30 ultrasound imaging system. Furthermore the Aixplorer SWE has also been cleared by the FDA as an aid to clinical management of adult and pediatric patients with liver disease such as fibrosis and steatosis.
As the world’s most utilized medical imaging modality, ultrasound is likely to be featured heavily at the 2018 Radiologi ...
August 18, 2017 — SuperSonic Imagine recently introduced the newest version of its premium ultrasound system, Aixplorer ...
SuperSonic Imagine presented the new version of Aixplorer for the first time at Journées Françaises de Radiologie (JFR) in Paris, Oct. 14-17. The newly released upgrade to Aixplorer, the UltraFast ultrasound system, enhances performance, workflow and efficiency while adding new features.
This was a strong year for ultrasound technology, with several groundbreaking systems and technologies making waves in ...
SuperSonic Imagine announced a partnership with U.S.-based Unetixs Vascular Inc. to bring SuperSonic Imagine’s technology to more customers in the vascular market.
The U.S. ultrasound market reached an all-time high of $1.44 billion in 2013 — a growth of almost 3 percent over 2012, according to Klein Biomedical Consultants’ “The Medical Diagnostic Ultrasound Market in the USA: Challenges & Opportunities in the New Millennium” 2013 report. Areas that contributed to market growth included musculoskeletal ultrasound and point-of-care ultrasound, which saw double-digit growth in 2013. “In spite of the uncertainties caused by the Affordable Care Act, continued declines in reimbursement and slow economic growth, we saw an uptick in ultrasound purchases,” said Harvey Klein, Ph.D., market analyst and author of the report.